180 Life Sciences Corp (ATNF)
1.97
-0.02
(-1.01%)
USD |
NASDAQ |
May 02, 16:00
1.97
0.00 (0.00%)
After-Hours: 17:21
180 Life Sciences Total Assets (Quarterly): 5.260M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 5.260M |
| September 30, 2023 | 4.958M |
| June 30, 2023 | 13.67M |
| March 31, 2023 | 14.92M |
| December 31, 2022 | 19.65M |
| September 30, 2022 | 34.34M |
| June 30, 2022 | 53.36M |
| Date | Value |
|---|---|
| March 31, 2022 | 59.68M |
| December 31, 2021 | 62.71M |
| September 30, 2021 | 65.07M |
| June 30, 2021 | 56.27M |
| March 31, 2021 | 60.11M |
| December 31, 2020 | 55.53M |
| December 31, 2019 | 51.88M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.958M
Minimum
Sep 2023
65.07M
Maximum
Sep 2021
39.81M
Average
52.62M
Median
Total Assets (Quarterly) Benchmarks
| Seelos Therapeutics Inc | 5.418M |
| Altimmune Inc | 210.64M |
| GT Biopharma Inc | 14.11M |
| Outlook Therapeutics Inc | 21.68M |
| MAIA Biotechnology Inc | 7.567M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 5.387M |
| Shareholders Equity (Quarterly) | -0.1277M |